You are here: Industry Insights > SMi

News List

Risk for Dementia Diagnosis Up for Seniors With Schizophrenia drugs
June 25, 2021
Older adults with schizophrenia have an increased risk for receiving a diagnosis of dementia compared with those without serious mental illness (SMI), according to a study published in the June issue of JAMA Psychiatry.
Wearable Injectors and Connected Devices Conference 2019 worldpharmanews
May 16, 2019
Wearable Injectors and Connected Devices Conference 2019.
Common medications for physical health may also treat mental illness pharmaceutical-technology
January 14, 2019
A large study led by University College London (UCL) has found that cheap, common physical health drugs could help treat serious mental illness (SMI) such as schizophrenia and bipolar disorder.....
SMi presents the launch of Cell & Gene Therapy 2018 worldpharmanews
May 23, 2018
SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018, with an interactive pre-conference workshop on the 9th October.
SMi presents the 9th Conference on Biosimilars & Biobetters worldpharmanews
May 11, 2018
The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK.
SMi presents the 9th Conference on Biosimilars & Biobetters worldpharmanews
May 08, 2018
26 - 27 September 2018, London, UK. The SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters, taking place on 26th & 27th September in Central London, UK.